Cargando…
Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis
We treated skin sclerosis with triple therapy consisting of a glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis. The objective of this study was to analyze its effectiveness in a case series of patients who received triple therapy. We enrolled 8 patients with diffuse...
Autores principales: | Suga, Kensuke, Yamashita, Hiroyuki, Takahashi, Yuko, Katagiri, Daisuke, Hinoshita, Fumihiko, Kaneko, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478820/ https://www.ncbi.nlm.nih.gov/pubmed/32150064 http://dx.doi.org/10.1097/MD.0000000000019301 |
Ejemplares similares
-
Efficacy and safety of dual filtration plasmapheresis combined with biological agents in active refractory rheumatod arthritis: A retrospective cohort study
por: Xing, Yida, et al.
Publicado: (2020) -
Fructose Malabsorption in Systemic Sclerosis
por: Marie, Isabelle, et al.
Publicado: (2015) -
Anti-HMGCR antibodies in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2016) -
Gastrointestinal involvement in systemic sclerosis: An updated review
por: Nassar, Mahmoud, et al.
Publicado: (2022) -
Rituximab in systemic sclerosis: A protocol for systematic review
por: Caldas, Marina Maria Vieira de Figueiredo, et al.
Publicado: (2019)